Photo gallery: necrobiosis lipoidica and granuloma annulare
- 作者: Olisova O.Y.1, Teplyuk N.P.1, Rogozina V.A.1
-
隶属关系:
- The First Sechenov Moscow State Medical University
- 期: 卷 28, 编号 5 (2025)
- 页面: 633-638
- 栏目: PHOTO GALLERY
- URL: https://ogarev-online.ru/1560-9588/article/view/359059
- DOI: https://doi.org/10.17816/dv692131
- EDN: https://elibrary.ru/ZPHOMJ
- ID: 359059
如何引用文章
详细
Necrobiosis lipoidica and granuloma annulare are rare chronic, non-infectious (inflammatory) skin diseases.
Necrobiosis lipoidica is characterized by bright-pink papules and plaques that transform into red or yellowish ring-shaped plaques and may be accompanied by telangiectasis, central atrophy, induration, and ulceration. Granuloma annulare is distinguished by isolated ring-shaped plaques or disseminated skin lesions with papules, patches, and bright-pink ring-shaped foci.
Necrobiosis lipoidica and granuloma annulare are common in patients with comorbidities such as type 1 and 2 diabetes mellitus, autosomal dominant maturity-onset diabetes of the young (MODY), endocrinopathy (thyroid and adrenal gland diseases), and chronic upper respiratory tract infections. The high incidence of comorbidities necessitates a multidisciplinary approach to the treatment of these conditions.
Necrobiosis lipoidica and granuloma annulare are treated using topical, systemic, and physical therapy modalities. Topical treatment includes topical glucocorticoids and calcineurin inhibitors. Systemic glucocorticoids are used for systemic therapy. Furthermore, the use of chloroquine, hydroxychloroquine, fumarates, and genetically engineered biological drugs has been reported. Physical therapy modalities include ultraviolet A and B radiation (UVA, UVB), PUVA therapy (UVA + photosensitizer), CO2 lasers, dye lasers, and intense pulsed light (IPL) therapy. However, none of the available therapeutic options show absolute efficacy, and long-term remission is extremely rare.
This photo gallery illustrates the heterogeneity of necrobiosis lipoidica and granuloma annulare symptoms to facilitate timely diagnosis and optimal treatment.
作者简介
Olga Olisova
The First Sechenov Moscow State Medical University
编辑信件的主要联系方式.
Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
SPIN 代码: 2500-7989
MD, Dr. Sci. (Medicine), Professor, Сorresponding Member of the Russian Academy of Sciences
俄罗斯联邦, MoscowNatalia Teplyuk
The First Sechenov Moscow State Medical University
Email: Teplyukn@gmail.com
ORCID iD: 0000-0002-5800-4800
SPIN 代码: 8013-3256
MD, Dr. Sci. (Medicine), Professor
俄罗斯联邦, MoscowVarvara Rogozina
The First Sechenov Moscow State Medical University
Email: varvara.rgzn@gmail.com
ORCID iD: 0000-0002-5471-6130
SPIN 代码: 3505-7408
俄罗斯联邦, Moscow
参考
补充文件








